Search clinical trials for: Tipranavir low dose

Total 12133 results

Innovent Biologics (Suzhou) Co. Ltd.

Completed

Single Dose Tolerability and Pharmacokinetics of IBI112 in Healthy Subjects

Healthy Subjects

China
Boehringer Ingelheim

Completed

Effects of Tipranavir/Ritonavir on the Pharmacokinetic Characteristics of Triple Drug Nucleoside and Non-nucleoside Reverse Transcriptase Inhibitor Therapy in HIV-1-infected Subjects

HIV Infections
Boehringer Ingelheim

Terminated

Tipranavir and Ritonavir vs. Saquinavir and Ritonavir Used With Two Nucleoside Reverse Transcriptase Inhibitors in Single Protease Inhibitor-experienced HIV-1 Patients

HIV Infections
Boehringer Ingelheim

Completed

Effects of Tipranavir (TPV) and Ritonavir (RTV) on the Pharmacokinetic Characteristics of Tenofovir Disoproxil Fumarate in Healthy Volunteers

Healthy
Hebrew University of Jerusalem
aMoon fund

Completed

Examining the Effectiveness of a Tablet Video Game on Mood and Cognition (THRIVE)

Depressive Symptoms | Mood Disturbance

Israel
Boehringer Ingelheim

Completed

Tipranavir/Ritonavir vs. Genotypically Defined Protease Inhibitor/Ritonavir in HIV Patients (RESIST-2)

HIV Infections

Argentina, Austria, Belgium, Brazil, Denmark, France, Germany, Greece, Ireland, Italy, Mexico, Netherlands, Portugal, Spain, Sweden, Switzerland, United Kingdom
Pluristem Ltd.

Completed

Safety and Efficacy of Allogeneic Cells for the Treatment of Intermittent Claudication(IC)

Intermittent Claudication | Peripheral Artery Disease

United States, Germany, Korea, Republic of, Israel
Boehringer Ingelheim

Completed

Exploratory Study of Tipranavir and Ritonavir in Multiple Protease Inhibitor-experienced HIV Patients

HIV Infections
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

Ultra Low Dose Radiation Delivered Before or After Chemotherapy-Free Targeted Therapy in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

Recurrent Mantle Cell Lymphoma | Refractory Mantle Cell Lymphoma

United States
Emory University
National Cancer Institute (NCI)

Terminated

Radiation Eliminates Storming Cytokines and Unchecked Edema as a 1-Day Treatment for COVID-19 (RESCUE 1-19)

Pneumonia | Coronavirus Infection in 2019 (COVID-19) | Severe Acute Respiratory Syndrome (SARS) Pneumonia

United States
MedImmune LLC

Completed

A Study to Evaluate Safety and Pharmacodynamic Efficacy of 0382 in Obese Subjects With NAFLD/NASH.

Non-alcoholic Fatty Liver Disease (NAFLD) | Non-alcoholic Steatohepatitis (NASH)

United States, Puerto Rico
Beijing Northland Biotech. Co., Ltd.

Completed

Safety and Efficacy Study of Thymosin Beta 4 in Patients With Acute Myocardial Infarction.Infarction

Acute Myocardial Infarction

China
Lucozade Ribena Suntory
King's College London

Completed

Acute Effects of Blackcurrant and Citrus Polyphenol Extracts on Postprandial Glycaemia (Glu-FX)

Postprandial Period

United Kingdom
Boehringer Ingelheim

Terminated

Effect of Tipranavir and Ritonavir on the Pharmacokinetic Characteristics of Norethindrone-Ethinyl Estradiol in Healthy Female Adult Volunteers

Healthy
Indonesia University
Medika Natura Sdn Bhd

Completed

Dose-ranging Study of SKF7™ for Obesity

Obesity

Indonesia
Postgraduate Institute of Medical Education and...

Completed

Utility of LDCT in Lung Cancer Screening in a TB Endemic Region

Lung Cancer

India
Yiling Pharmaceutical Inc.

Completed

A Phase I Pharmacokinetics Study for KT07 Capsule

Pharmacokinetics | Healthy Adult Subjects | Safety and Tolerability

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Recruiting

Feasibility of Cell-Free DNA Liquid Biopsy in Screening High-Risk Patients for Lung Cancer

Lung Carcinoma

United States
CalciMedica, Inc.

Completed

CM4620 Injectable Emulsion Versus Supportive Care in Patients With Acute Pancreatitis and SIRS

Systemic Inflammatory Response Syndrome | Acute Pancreatitis

United States
VA Office of Research and Development

Terminated

Frequent, Low-Dose Erythropoietin A Mechanistic Approach to Mitigate Adverse Cardiovascular Effects of Erythropoietin

Atherosclerosis | Anemia | CKD | Cardiovascular

United States
Columbia University
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Obesity, Oral Contraception, and Ovarian Suppression (20/30)

Ovarian Suppression

United States
Spectrum Dynamics
Brigham and Women's Hospital; Cedars-Sinai Medical Center; Oregon Heart and Vascular...

Completed

Low Dose One-Day Tc99m Protocol With a High-Efficiency Cardiac Dedicated Gamma Camera For Detection of Coronary Disease

Chest Pain

United States
Milton S. Hershey Medical Center

Completed

Computed Tomography Arteriograms (CTA) Volume Dose Reduction Study

Aortic Aneurysm | Contrast Induced Nephropathy | Aortic and Arterial Anomalies

United States
Tatyana Zubkova
St. Petersburg State Pavlov Medical University; MDP-CRO, LLC

Completed

Evaluation of Corfluvec Vaccine for the Prevention of COVID-19 in Healthy Volunteers

COVID-19

Russian Federation
CANbridge (Suzhou) Bio-pharma Co., Ltd.

Recruiting

Phase 1/2 Study of CAN103 in Subjects With Gaucher Disease

Gaucher Disease, Type 1 | Gaucher Disease, Type 3

China
St. Olavs Hospital
Norwegian University of Science and Technology

Recruiting

Exercise Training as Medicine for Substance Use Disorder Patients

Substance Use Disorders

Norway
Reneo Pharma Ltd

Completed

A Phase 1b Study of the Safety of REN001 in Patients With Fatty Acid Oxidation Disorders

Fatty Acid Oxidation Disorders

United States, France, Spain
Clementia Pharmaceuticals Inc.

Completed

Study to Compare the Pharmacokinetics, Safety, and Tolerability Following Administration of Palovarotene in Healthy Japanese and Non-Asian Subjects

FOP
Beijing Friendship Hospital

Unknown

Ruxolitinib as a Salvage Therapy for Hemophagocytic Lymphohistiocytosis

Hemophagocytic Lymphohistiocytosis

China
RWTH Aachen University
Heinrich-Heine University, Duesseldorf

Withdrawn

Peripheral Artery Occlusive Diseases (PAOD) Study - Clinical Assessment

Peripheral Artery Disease

Germany
Boehringer Ingelheim

Completed

A Study in Healthy People to Measure the Amount of BI 655130 in the Blood After Injecting Different Doses Into Different Parts of the Body

Healthy

Belgium
Kyoung Ho Lee, MD
Seoul National University Bundang Hospital; Ministry of Health & Welfare, Korea and other collaborators

Completed

Low vs. Standard Dose CT for Appendicitis Trial (LOCAT)

Appendicitis

Korea, Republic of
Institute of Liver and Biliary Sciences, India

Completed

Low Dose Albumin Versus Standard Dose Albumin in High Risk Spontaneous Bacterial Peritonitis.

Spontaneous Bacterial Peritonitis

India
Boehringer Ingelheim

Completed

Pharmacokinetics of Faldaprevir of Soft Capsule

Healthy

China
Biogen

Completed

Phase 1 Study to Evaluate the PK, Safety, Tolerability of BIIB023 in Chinese, Japanese, and Caucasian Healthy Volunteers

Healthy Volunteers

Australia, China
Oryn Therapeutics, LLC

Completed

Randomized, Double-blind, Vehicle Controlled, Repeat Dose Comparative Study in RA Patients Managed With DMARDs

Rheumatoid Arthritis

United States
University Hospital, Basel, Switzerland

Completed

Efficacy Study Comparing the Effect of Clomiphencitrate to an Antagonist Protocol (CANTAPOR)

Female Infertility | Ovarian Insufficiency

Switzerland
University of Oxford
Medical Research Council

Terminated

Safety and Immunogenicity of MVA.HIVconsv in HIV-1 Seropositive Adults on HAART

HIV-1

United Kingdom
InnoCare Pharma Inc.
Beijing InnoCare Pharma Tech Co., Ltd.

Recruiting

Evaluating Different Doses of Orelabrutinib in MCL

Mantle Cell Lymphoma

China
Gyroscope Therapeutics Limited
Novartis Pharmaceuticals

Active, not recruiting

EXPLORE: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005 (EXPLORE)

Dry Age-related Macular Degeneration

United States, Germany, United Kingdom, Spain, Poland, Australia, France, Netherlands
Lexeo Therapeutics

Recruiting

Gene Therapy for Cardiomyopathy Associated With Friedreich's Ataxia

Friedreich Ataxia | Cardiomyopathy, Secondary

United States, Canada
Oblato, Inc.

Recruiting

Study of Safety and Pharmacokinetic Properties of Oral OKN-007 in Patients With Recurrent High-Grade Glioma

Astrocytoma | Glioblastoma Multiforme | Oligodendroglioma | High-grade Glioma

United States
Montana State University

Completed

Impact of Cottonseed Oil on Oxidative Stress, Inflammation, and Metabolism

Inflammation | Healthy | Metabolic Syndrome | Oxidative Stress

United States
National Institute of Diabetes and Digestive and...
Washington University School of Medicine; University of Alabama at Birmingham; Icahn School of Medicine at Mount Sinai and other collaborators

Completed

Effect of Dialysis Dose and Membrane Flux in Maintenance Hemodialysis (HEMO)

End Stage Renal Disease

United States
Taiho Pharmaceutical Co., Ltd.

Recruiting

A Study of TAS3731 in Healthy Adults

Healthy Adult Males

Japan
Tasly Pharmaceutical Group Co., Ltd

Not yet recruiting

Efficacy and Safety of Jiuweihuaban Pill for Treating Plaque Psoriasis

Plaque Psoriasis

China
LimmaTech Biologics AG
GlaxoSmithKline

Completed

Safety and Immunogenicity of a Klebsiella Pneumoniae Tetravalent Bioconjugate Vaccine (Kleb4V)

Klebsiella Pneumoniae Infection

Germany
Precigen Actobio T1D, LLC
TFS Trial Form Support; Intrexon Actobiotics NV, d/b/a Precigen Actobio

Completed

A Study to Assess the Safety and Tolerability of Different Doses of AG019 Administered Alone or in Combination With Teplizumab in Participants With Recently Diagnosed Type 1 Diabetes Mellitus (T1D)

Diabetes Mellitus, Type 1

United States, Belgium
Sang-Won Um

Not yet recruiting

A Prospective Study for the Early Diagnosis of Lung Cancer in Korean Females

Health Risk Behaviors
Sichuan Cancer Hospital and Research Institute

Not yet recruiting

Neoadjuvant Chemotherapy and Low-dose Radiotherapy Sequential Concurrent Chemoradiotherapy for Locally Advanced Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

Search clinical trials for: Tipranavir low dose

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Luxembourg

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations